Clinical Trials on Genitourinary Cancer in China

Total 7231 results

RenJi Hospital

Active, not recruiting

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer (NeoATP)

Breast Cancer Female

China
The Hong Kong Polytechnic University
The Affiliated Hospital Of Southwest Medical University

Terminated

Acupuncture for Joint Symptoms in Patients With Breast Cancer

Female Breast Cancer

China
Fudan University

Active, not recruiting

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Metastatic Breast Cancer

China
Taizhou EOC Pharma Co., Ltd.

Active, not recruiting

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Breast Cancer Female

China
Peking University

Completed

Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.

Invasive Breast Cancer

China
Fudan University

Completed

A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Breast Cancer Female

China
Xichun Hu

Completed

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

Metastatic Breast Cancer

China
Hospital Affiliated to Military Medical Science...

Unknown

The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer (PROOF)

Metastatic Breast Cancer

China
Fudan University

Completed

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Peking Union Medical College Hospital

Recruiting

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer (MAP-01)

Pancreatic Cancer | Metastatic Cancer | Advanced Cancer

China
Peking University

Recruiting

Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer

Gastric Cancer | Colo-rectal Cancer

China
Harbin Medical University

Recruiting

The Effect of ePRO on Quality of Life and Prognosis of Patients With Unresectable Metastatic Colorectal Cancer

Cancer | Colorectal Cancer Metastatic

China
Peking University Cancer Hospital & Institute

Not yet recruiting

KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma

HER2-positive Colorectal Cancer | HER2-positive Biliary Tract Cancer

China
Broncus Medical Inc
Uptake Medical Technology, Inc.

Terminated

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell

China
Second Affiliated Hospital, School of Medicine,...
Sir Run Run Shaw Hospital; Zhejiang Provincial People's Hospital

Active, not recruiting

Construction and Validation of Risk Prediction Model for PICC Catheter Displacement

Cancer Patients With PICC

China
Shandong Suncadia Medicine Co., Ltd.

Recruiting

Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

Unresectable or Metastatic Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Recruiting

A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer

HER-2 Positive Breast Cancer

China
Fudan University

Unknown

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

HER-2 Negative Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab

HER2 Positive Metastatic Breast Cancer

China
China Medical University, China

Unknown

Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer

Gastrointestinal Cancer

China
Fudan University
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Recruiting

Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer

Early-stage Breast Cancer

China
Peking University

Recruiting

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

HER2-positive Breast Cancer

China
Biyun Wang, MD

Completed

18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response

HER2-positive Breast Cancer

China
Guangdong Provincial People's Hospital

Unknown

TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer

HER2-Positive Breast Cancer

China
SMR Biotech Co., Ltd.

Terminated

A Study of the Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy

Colorectal Cancer | Neuropathy | Advanced Gastric Cancer

China
Hunan Province Tumor Hospital

Completed

Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)

Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage II

China
Sun Yat-sen University

Terminated

Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer (SYSUCC-007)

Metastatic Triple Negative Breast Cancer

China
The Second Hospital of Shandong University

Recruiting

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Esophageal Cancer | Immunotherapy | Gastroesophageal Cancer | Adjuvant

China
Sun Yat-sen University
The First Affiliated Hospital of Guangzhou Medical University; Sixth Affiliated...

Recruiting

RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial (RAMEC)

Hepatectomy | Primary Liver Cancer | Immunotherapy | Radiofrequency Ablation

China
Betta Pharmaceuticals Co., Ltd.

Recruiting

A Phase I Study of BPI-16350 in Patients With Advanced Solid Tumor

Advanced Solid Cancer

China
Shandong Cancer Hospital and Institute

Unknown

Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors

Advanced Cancer | Radiation Toxicity | Radiosensitivity

China
The Affiliated Hospital of Qingdao University

Recruiting

A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer (CLASS14)

Gastric Cancer Stage III | Gastric Cancer Stage II

China
Huihua Xiong

Not yet recruiting

Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer

Metastatic Triple-negative Breast Cancer

China
Sun Yat-sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Metastatic Biliary Tract Cancer | Locally Advanced Biliary Tract Cancer

China
Aiping Shi

Recruiting

Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC)

China
Fujian Cancer Hospital

Not yet recruiting

Apatinib Combined With Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

Advanced Triple Negative Breast Cancer

China
Guangdong Provincial Hospital of Traditional Chinese...

Recruiting

Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer (LBDL)

Gastric Cancer Stage III | Gastric Cancer Stage II

China
Chongqing Precision Biotech Co., Ltd

Recruiting

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

Gynecologic Cancer | Ovarian Cancer | Metastatic Cancer | Cervix Cancer | Advanced Cancer

China
Luye Pharma Group Ltd.

Unknown

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer Recurrent

China
Fudan University

Recruiting

Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype (BCTOP-T-M03)

Metastatic Breast Cancer | Triple Negative Breast Cancer | Mutation

China
Peking University People's Hospital

Recruiting

Assessment of Breast Cancer-Related Arm Lymphedema

Breast Cancer

China
Eli Lilly and Company

Completed

A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers

Metastatic Cancer | Advanced Cancer

China
Protgen Ltd

Unknown

Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer

Liver Cancer

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer

HER2-positive Breast Cancer

China
Huashan Hospital

Recruiting

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

HER2-positive Breast Cancer

China
Fudan University

Recruiting

Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer

Breast Cancer Stage I

China

3

Subscribe